By
David Williamson
|
More Articles
November 9, 2012
|
In this video, Motley Fool health care analyst David Williamson takes a look at three biotech stocks making moves today and what you should know about them. Sequenom (Nasdaq: SQNM ) made a big jump today despite higher-than-expected losses because of continued interest in its MaterniT21 Down syndrome test. SciClone Pharmaceuticals (Nasdaq: SCLN ) released some disappointing numbers. And ISIS Pharmaceuticals (Nasdaq: ISIS ) is up 15% after a recent buy rec from Cowen, but Williamson warns that there are some mitigating factors around ISIS that should curb investors' enthusiasm.
While you can certainly make huge gains in biotech and pharmaceuticals, the best investing approach is to choose great companies and stick with them for the long term. In our free report "3 Stocks That Will Help You Retire Rich," we name stocks that could help you build long-term wealth and retire well, along with some winning wealth-building strategies that every investor should be aware of. Click here now to keep reading.